RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

Clinical trial NCT02257177 · COMPLETED

Trial details

NCT number: NCT02257177
Sponsor: Galecto Biotech AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2014-09-01
Primary completion: 2016-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.